On November 8, 2023, the final round of the 8th Tsinghua Alumni Entrepreneurship & Innovation Competition for Health and Medicine was successfully held at the Dongsheng International Science Park in Haidian District, Beijing. The event was attended by over 200 participants, including Shizongkai, Vice Chairman of the Tsinghua University Alumni Association and Director of the Tsinghua Alumni Entrepreneurship & Innovation Competition Organizing Committee; Huang Tianyin, Vice Provost of Tsinghua University, Dean and Chair Professor of the School of Medicine, Academician of the Singapore National Academy of Sciences, and Foreign Academician of the National Academy of Medicine of the United States; Yang Liu, Vice Director of the Tsinghua University Alumni Office, Deputy Secretary-General of the Tsinghua University Alumni Association, and Deputy Director of the Tsinghua Alumni Entrepreneurship & Innovation Competition Organizing Committee; Yuan Jianxiong, Secretary-General of the Tsinghua Alumni Entrepreneurship & Innovation Competition; Wang Xia, Executive Secretary-General of the Tsinghua Alumni Entrepreneurship & Innovation Competition and Director of the Strategic Development Department of the Tsinghua University Institute of Smart Healthcare; Yu Yongping, Deputy Secretary-General of the Tsinghua Alumni Entrepreneurship & Innovation Competition and Secretary-General of the Life Sciences and Medical Health Special Committee of the Tsinghua University Alumni Association; as well as government officials from various regions, representatives from Tsinghua University alumni associations, investors, industry representatives in the healthcare sector, and representatives of participating projects.

A total of 607 projects were registered for this year's Tsinghua Alumni Entrepreneurship & Innovation Competition, with 132 projects in the healthcare and medicine category. After three city-level preliminary competitions in Qingdao, Nantong, and Dongguan, 52 outstanding projects were selected to participate in the final round. Following fair and transparent evaluation, the top ten projects were chosen in the Seed, Angel, and Growth categories.

During the final round, Dr. Jin Feng, Vice General Manager of Research and Development at NewDEL Biotech, delivered a presentation on the "DEL3.0 Technology Platform (DEL Live Cell Screening Technology Integrated with AI)" from dimensions including "Background and Development History," "Advantages and Differentiation of DEL3.0 Technology," "Core Team," "Business Model," "Pipeline Layout," and "Strategic Planning." Amidst numerous outstanding industrialization projects in this year's Tsinghua Entrepreneurship & Innovation Competition, NewDEL Biotech stood out and was honored with the Top Ten Prize in the Growth category of the global final for health and medicine.